Abcellera Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Abcellera Contact Number

Contact AbCellera

3 hours ago Abcellera.com Show details

AbCellera Biologics Inc. 2215 Yukon Street Vancouver, BC V5Y 0A1

Category: Cell Phone, Contact SupportShow more

AbCellera Biologics Inc. Contact FAQ

6 hours ago Investors.abcellera.com Show details

ABCL’s CUSIP and ISIN numbers are: CUSIP#: 00288U 106 ISIN#: CA00288U1066

Category: Cell Phone, Contact SupportShow more

AbCellera Biologics Inc Company Profile Vancouver, BC

7 hours ago Dnb.com Show details

(604) 559-9005

Phone. (604) 559-9005. Company Description. AbCellera Biologics Inc is located in Vancouver, BC, Canada and is part of the Biotechnology Research Services Industry. AbCellera Biologics Inc has 10 total employees across all of its locations and generates $2.35 million in sales (USD).

Employees: 10
Phone: (604) 559-9005
Location: 2215 Yukon St, Vancouver, V5Y 0A1, BC

Category: Cell PhoneShow more

AbCellera Biologics Inc. Contact Request Info

5 hours ago Investors.abcellera.com Show details

604.559.9005

Contact us. AbCellera Biologics Inc. 2215 Yukon Street Vancouver, BC V5Y 0A1 office: 604.559.9005. Legal. Privacy Policy ©

Category: Cell Phone, Contact SupportShow more

AbCellera Biologics Crunchbase Investor Profile

9 hours ago Crunchbase.com Show details

(604) 559-9005

Phone Number (604) 559-9005. AbCellera focuses on therapeutic antibodies, screening, choosing, and analyzing millions of naturally produced antibodies to be used as next-generation drug candidates. It specializes in the fields of biotechnology, medicine, and therapeutics.

Founded: 2012
Founders: Carl Hansen, Véronique Lecault, Kevin Heyries

Category: Cell PhoneShow more

AbCellera Biologics Inc. Profile

3 hours ago Sedar.com Show details

AbCellera Biologics Inc. Mailing Address: 2215 Yukon Street Vancouver, British Columbia V5Y 0A1: Head Office Address: 2215 Yukon Street Vancouver, British Columbia V5Y 0A1: Contact Name: Tryn Stimart: Principal Regulator: Non-Reporting Issuer: Business e-mail address: [email protected]abcellera.com: Short Form Prospectus Issuer: No: Telephone

Category: Cell PhoneShow more

Team AbCellera

Just Now Abcellera.com Show details

Contact; Careers; Team Human potential, magnified. Meet the team. Show all. Filter by focus Team. Reset Filters. Show all. Growing strong. Who we are. At AbCellera, team is everything. When great people share a vision and work together, they can truly have a positive impact on the world. That’s why we hire for character and intelligence, not

Category: Cell PhoneShow more

AbCellera Biologics Company Profile Office Locations

6 hours ago Craft.co Show details

AbCellera Biologics has 302 employees at their 1 location and $11.61 M in annual revenue in FY 2019. See insights on AbCellera Biologics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Category: Cell PhoneShow more

AbCellera Profile on TNet BC technology

2 hours ago Bctechnology.com Show details

4,949 Company Profile Views. Company Overview. AbCellera is a privately held company located in Vancouver, Canada, that is a world-leading innovator in antibody discovery for therapeutics, and immune profiling for vaccine research. AbCellera works in partnerships with researchers from academia, non-profit organizations, and industry to enable

1. Contact Number ·
2. contact number
3. Contact Number ·
4. contact number

Category: Cell Phone, Tech SupportShow more

AbCellera Company Profile: Stock Performance & …

8 hours ago Pitchbook.com Show details

AbCellera General Information Description. AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes, and analyzes antibody responses to engineer new antibody drug candidates for its partners.

1. Contact Number ·
2. contact number
3. Contact Number ·
4. contact number

Category: Cell PhoneShow more

Rohit S. CoFounder ScriptSides LinkedIn

6 hours ago Ca.linkedin.com Show details

The team I'm leading at AbCellera in Vancouver is growing! We're hiring research scientists and ML engineers for a number of roles in the sequence… Liked by Rohit S. 2020 was an eventful year, and we couldn't have done it without you! Contact Rohit directly Join to view full profile Others named Rohit S. Rohit S

Title: MD/PhD Candidate | Vanier …
Location: Vancouver, British Columbia, Canada
Connections: 306

Category: Contact NumberShow more

AbCellera Reports Q2 2021 Business Results

3 hours ago Abcellera.com Show details

(236) 521-6774

Media: Jessica Yingling, Ph.D.; [email protected], +1(236) 521-6774. paragraph. Business Development: Neil Berkley; [email protected], +1(604) 559-9005. paragraph. Investor Relations: Melanie Solomon; [email protected], +1(778) 729-9116. paragraph

Category: Cell PhoneShow more

AbCellera Biologics Inc. Contact Email Alerts

5 hours ago Investors.abcellera.com Show details

604.559.9005

Contact us. AbCellera Biologics Inc. 2215 Yukon Street Vancouver, BC V5Y 0A1 office: 604.559.9005. Legal. Privacy Policy ©

Category: Cell Phone, Contact SupportShow more

Contact Lexcelera

4 hours ago Lexcelera.com Show details

55 28 88

1055 West Georgia Street. P.O. BOX 11117. Vancouver BC V6E 4N7. Canada. +33 1 55 28 88 00.

1. Abcellera
2. Abcellera

Category: Contact SupportShow more

Emergency Use Authorization of AbCelleraDiscovered

8 hours ago Abcellera.com Show details

Source: AbCellera Biologics Inc. Inquiries. Media: Jessica Yingling, Ph.D.; [email protected], +1(236)521-6774. Business Development: Neil Berkley; [email protected], +1(604)559-9005 . Investor Relations: Melanie Solomon; [email protected], +1(778)729-9116

Category: Cell PhoneShow more

AbCellera Biologics, Inc. (ABCL) Company Profile

6 hours ago Stockanalysis.com Show details

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, AI-powered drug discovery platform searches and analyzes the database of natural immune systems to find antibodies that can be developed as drugs. As of December 31, 2020, the company had 103 discovery programs that are either completed, in progress, or under contract.

Category: Cell PhoneShow more

Career openings at AbCellera

2 hours ago Abcellera.com Show details

Team; Technology; Partnership; News & Events; Investors; Contact; Careers; Career openings at AbCellera Current openings. Contact us. Do you dream big and want to make an impact?

Category: Cell PhoneShow more

AbCellera FierceBiotech

6 hours ago Fiercebiotech.com Show details

AbCellera is best known for its Eli Lilly-partnered attempt to create what could be the world’s first antibody drug against SARS-CoV-02. to first contact to close in 13 days.

Category: Cell Phone, Tech SupportShow more

AbCellera Biologics Inc. AbCellera Reports Q2 2021

1 hours ago Investors.abcellera.com Show details

Started discovery on six programs, bringing the cumulative number of program starts to 60. Confirmed three new molecules advanced into the clinic, bringing the cumulative total to four. U.S. shipments of the AbCellera-discovered and Eli Lilly-developed bamlanivimab, administered together with etesevimab for COVID-19, were halted in June 2021

Category: Cell PhoneShow more

Abcellera Leverages AWS to Accelerate Drug Development

3 hours ago Youtube.com Show details

AbCellera applied its AI-powered technology platform, which leverages AWS, to help bring the world’s first COVID-19 antibody drug candidate into human clinic

1. Contact Number ·
2. contact number
3. Contact Number ·
4. contact number

Category: Cell PhoneShow more

AbCellera Biologics Funding, Financials, Valuation

9 hours ago Crunchbase.com Show details

AbCellera Biologics has raised a total of $371.2M in funding over 11 rounds. Their latest funding was raised on May 27, 2020 from a Series B round. AbCellera Biologics is registered under the ticker NASDAQ:ABCL . Their stock opened with $20.00 in its Dec 10, 2020 IPO. AbCellera Biologics is funded by 12 investors.

Category: Cell PhoneShow more

Progress + Pipeline » EQRx

3 hours ago Eqrx.com Show details

We launched in January 2020 to tackle the next frontier of innovation: reducing the cost of medicine. Through strategic partnerships with stakeholders from across the healthcare ecosystem and cutting-edge science and technology, we aim to provide high-quality, patent-protected medicines more efficiently and cost-effectively than ever before. See pipeline… Here is a …

Category: Contact NumberShow more

Salipro Biotech enters into a collaboration and license

9 hours ago Salipro.com Show details

Salipro Biotech enters into a collaboration and license agreement with AbCellera for access to the Salipro® Platform for antibody discovery against GPCRs, ion channels, and transporters The collaboration enables AbCellera to access Salipro Biotech’s unique expertise and its Salipro® platform technology to generate stable antigens for challenging membrane …

Category: Tech SupportShow more

AbCellera Biologics Inc. Privacy Policy

7 hours ago Investors.abcellera.com Show details

AbCellera Biologics Inc. (ABCELLERA) respects the privacy of every individual who visits our Web site or responds to our interactive advertisements. please contact us at the e-mail address listed at the bottom of this policy. We will delete your information from our existing files. address, email address, phone number, and/or debit or

Category: Cell PhoneShow more

Laura Campbell Scientific Recruiter AbCellera LinkedIn

1 hours ago Ca.linkedin.com Show details

Oct 2020 - Present1 year 1 month. Vancouver, British Columbia, Canada. AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. Its full-stack, AI-powered drug discovery platform integrates modern technologies from

Title: Scientific Recruiter at AbCellera
Location: Vancouver, British Columbia, Canada
1. 500+ connections

Category: Cell PhoneShow more

AbCellera Antibody Engineering & Therapeutics Europe

4 hours ago Informaconnect.com Show details

AbCellera partners to discover and develop next-generation therapeutic antibodies. Our team integrates end-to-end capabilities in proprietary immunizations, microfluidics, genomics, and computation to develop innovative strategies that overcome tough challenges and advance discovery programs.

Category: Cell PhoneShow more

AbCellera Biologics Number of Employees 20222021 ABCL

6 hours ago Macrotrends.net Show details

AbCellera Biologics number of employees from 2022 to 2021. Number of employees can be defined as a measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis

Category: Cell PhoneShow more

AbCellera Reports Q2 2021 Business Results

Just Now Finance.yahoo.com Show details

AbCellera added 19 discovery programs in Q2 to reach a cumulative total of 138 discovery programs as of June 30, 2021 (up 82% from 76 on June 30, 2020), that are either completed, in progress, or

Category: Cell PhoneShow more

ABCELLERA BIOLOGICS INC. : ABCL Stock Price CA00288U1066

7 hours ago Marketscreener.com Show details

AbCellera Biologics Inc. (AbCellera) is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera's full-stack, artificial intelligence (AI)-powered drug discovery platform integrates technologies from engineering

Category: Cell PhoneShow more

John Hamer Net Worth, Biography & Insider Trading History

1 hours ago Insidertrades.com Show details

During the past quarter, John Hamer has sold $2,756,901.00 in AbCellera Biologics stock. Most recently, John Hamer sold 162,649 shares of the business's stock in a transaction on Tuesday, August 31st. The shares were sold at an average price of $16.95, for a …

Category: Contact NumberShow more

AbCellera Wikipedia

9 hours ago En.wikipedia.org Show details

AbCellera is a Vancouver, British Columbia-based biotechnology firm that researches and develops human antibodies to address pandemics and common diseases. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim …

1. Contact Number ·
2. contact number
3. Contact Number ·
4. contact number

Category: Cell PhoneShow more

AbCellera Biologics Inc. DEF 14A Apr. 28, 2021 4:00 PM

9 hours ago Seekingalpha.com Show details

To be held June 15, 2021. Notice is hereby given that the 2021 Annual Meeting of Shareholders, or Annual Meeting, of AbCellera Biologics Inc. will …

Category: Cell PhoneShow more

What Do Analysts Say About AbCellera Biologics Inc. (ABCL

5 hours ago Baxterreport.com Show details

ABCL – AbCellera Biologics Inc. Stock Earnings Estimates. Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 272.20 million.

Category: Cell PhoneShow more

How Do Analysts Feel About AbCellera Biologics Inc. (ABCL

2 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 269.70 million. ABCL does have institutional investors; and they hold 37.20% of the stock. AbCellera Biologics Inc. – Insider Activity and Holdings. Moreover, the latest SEC filings also revealed that stock came across 5 new insider purchases involving 2,533,333 shares.

Category: Cell PhoneShow more

Today in acquisitions: AbCellera, Mogo, Carebook, WELL

8 hours ago Betakit.com Show details

AbCellera acquires Trianni for $90 million USD. Vancouver-based biotech startup AbCellera, which is developing an antibody discovery tech company, has acquired San Francisco-based Trianni for $90 million USD. The deal comes seven months after AbCellera’s $144 million Series B round.

Category: Cell PhoneShow more

AbCellera Biologics Inc. (ABCL): The stock short term

6 hours ago Baxterreport.com Show details

The total number of common shares currently owned by the public is 272.20 million. ABCL does have institutional investors; and they hold 48.00% of the stock. AbCellera Biologics Inc. – Insider Activity and Holdings. Currently, the stock has been recommended as Strong Buy by 5 of the brokerage firms.

Category: Cell PhoneShow more

AbCellera Reports Full Year 2020 Business Results Bloomberg

1 hours ago Bloomberg.com Show details

March 29, 2021, 1:05 PM PDT. AbCellera Reports Full Year 2020 Business Results * Total revenue of $233 million^1 in 2020, up 1,908% year-over-year * Total revenue from research fees of $20 million

Category: Cell PhoneShow more

AbCellera Partners With Eli Lilly to Create COVID19

2 hours ago Brownstoneresearch.com Show details

Less than a month ago, AbCellera received a blood sample from a patient who recovered from COVID-19. The company used artificial intelligence (AI) to screen more than five million immune cells in that sample. And it identified about 500 antibodies that helped the patient fight off the virus. This is incredible.

Category: Cell PhoneShow more

AbCellera and IGM Biosciences Announce MultiYear Antibody

4 hours ago Globenewswire.com Show details

“We believe that AbCellera’s technology will assist us in rapidly identifying the best antibodies against a large number of agonist targets, as …

Category: Cell PhoneShow more

AbCellera Announces Pricing of Initial Public Offering

1 hours ago Businesswire.com Show details

(236) 521-6774

AbCellera explicitly disclaims any obligation to update any forward-looking statements except to the extent required by law. Contacts Jessica Yingling, Ph.D. +1 (236) 521-6774 [email protected]abcellera.com

Category: Cell PhoneShow more

ABCELLERA BIOLOGICS : Management's Discussion and Analysis

Just Now Marketscreener.com Show details

AbCellera also intends to disclose additional details about each molecule to the extent made public or permitted by its partners. We believe that the updated metric together with the additional list of molecules will give investors a better understanding of AbCellera's downstream portfolio and bring AbCellera's reporting in line with other

Category: Cell PhoneShow more

Emergency Use Authorization of AbCelleraDiscovered

3 hours ago Finance.yahoo.com Show details

VANCOUVER, British Columbia, September 16, 2021--EUA of Bamlanivimab Administered with Etesevimab Expanded by the FDA to Include Post-Exposure Prophylaxis for the Prevention of COVID-19

Category: Cell PhoneShow more

Emergency Use Authorization of AbCelleraDiscovered

4 hours ago Biospace.com Show details

“The expanded use authorization for bamlanivimab together with etesevimab provides a way to protect the significant number of people who, because of their situational exposure risk or medical condition, remain vulnerable to COVID-19,” said Carl Hansen, Ph.D., CEO and President of AbCellera.

Category: Cell PhoneShow more

What is Abcellera Biologics Valuation? ABCL Macroaxis

Just Now Macroaxis.com Show details

While the market cap of a public entity, such as Abcellera Biologics, is its stock price multiplied by the total number of shares outstanding, calculating Abcellera Biologics' enterprise value requires a different approach. It uses Abcellera Biologics' balance sheet items such as long-term debt, the book value of the preferred stock, minority

Category: Cell PhoneShow more

Would I Buy AbCellera Biologics Inc. (NASDAQ: ABCL) Stock

8 hours ago Stocksregister.com Show details

The number of analysts that have assigned ABCL a recommendation rating is 5. Out of them, 0 rate it a Hold, while 5 recommend Buy, whereas 0 assign an Overweight rating. 0 analyst(s) have tagged AbCellera Biologics Inc. (ABCL) as Underweight, while 0 advise Sell.

Category: Cell PhoneShow more

Abcellera Stock Investment (NASDAQ:ABCL) Macroaxis

6 hours ago Macroaxis.com Show details

Abcellera Biologics is selling for 15.37 as of the 10th of October 2021. This is a -2.6% down since the beginning of the trading day. The stock's lowest day price was 15.24. Get the latest Abcellera Biologics detailed stock quotes, stock trade data, stock price info, and performance analysis, including Abcellera Stock investment advice, charts, stats and more.

Category: Cell PhoneShow more

AbCellera Biologics : Emergency Use Authorization of

9 hours ago Marketscreener.com Show details

AbCellera (Nasdaq: ABCL) today announced the U.S. Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for bamlanivimab (LY-CoV555) 700 mg administered with etesevimab (LY-CoV016) 1400 mg to include post-exposure prophylaxis (PEP) to prevent SARS-CoV-2 infection or symptomatic COVID-19. The …

Category: Cell PhoneShow more

$ABCL: JUST IN – New data and price prediction is out now

4 hours ago Wallstreetfacts.com Show details

The 52-week high for AbCellera Biologics Inc is $71.91 and the low is $14.51. We will be moving onto the number of outstanding shares. One is that you can use shares outstanding to calculate the market capitalization, the total value, of a corporation.

Category: Contact NumberShow more

All Time Past 24 Hours Past Week Past month

Please leave your comments here:

Brand New Updated

Frequently Asked Questions

What kind of company is abcellera biologics inc?

AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes, and analyzes antibody responses to engineer new antibody drug candidates for its partners.

Who is abcellera and what does it do?

VANCOUVER, British Columbia-- (BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL), a technology company with a centralized operating system for next-generation antibody discovery, today announced financial results for the second quarter of 2021. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated.

How big is the new facility for abcellera?

AbCellera is also looking to continue boosting employee numbers, and it plans to open a new 48,000-square-foot R&D facility next year, as well as build out a GMP manufacturing facility for production of biologics for clinical testing.

How many programs has abcellera started to date?

AbCellera started discovery on an additional six programs in Q2 to reach a cumulative total of 60 program starts (up from 48 on June 30, 2020). Our partners advanced three additional molecules into the clinic in Q2 2021, bringing the cumulative total to four.

Brand New Updated

Popular Brands

Amazon
Abbvie
Aia
Asml
Amgen
Att
Apple
Adobe
Aptar
Acc
Adidas
Aak
Aes